NSEOutcome of Board Meeting10h ago · 3 Sept 2026, 08:11 pm

Outcome of Board Meeting

Orchid Pharma Limited · ORCHPHARMA

✦ AI SummaryMgmt Change

Orchid Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on September 03, 2026, where the Board of Directors approved the appointment of Cost Auditors for FY 2026-27, appointment of Mr. Arjun Dhanuka as Whole-Time Director, and other matters.

Analysis Scores

Earnings Impact2/10
Growth Catalyst3/10
Governance Concern5/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Orchid Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on September 03, 2026.

Attachments (1)

📄

ORCHPHARMA_03092026200939_Stx_ltr_outcome_sd.pdf

pdf

Download →
View document text
OrchidPharm~W September 03, 2026 National Stock Exchange of India Limited, BSE Limited Exchange Plaza, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Dalal Bandra (E), Mumbai-400051 Street, Fort, Mumbai-400001 Symbol: ORCHPHARMA Scrip Code: 524372 Subject: Outcome of Board Meeting - Orchid Pharma Limited ("the Company") Dear SirjMadam, With reference to the captioned subject and pursuant to Regulation 30 read with Schedule III of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations), as amended read with SEBI Master Circular no. SEBIj HOj49j14j14(7)2025-CFD-POD2jI/3762j2026, dated January 30, 2026, we would like to inform you that the Board of Directors of the Company at its meeting held today i.e. September 03, 2026 (commenced at 18:00 P.M. (IST) and concluded at 19:45 P.M. (IST) has inter-alia considered and approved below mentioned matters: 1. Appointment and recommendation of remuneration of Cost Auditors of the Company for the F.Y. 2026-27. Details as required under Regulation 30 read with SEBI Circular SEBIj HOj49j14j14(7)2025-CFD-POD2jI/3762j2026, dated January 30, 2026 are enclosed herewith as Annexure-I 2. Appointment and remuneration of Mr. Arjun Dhanuka (DIN: 00454689) as Whole-Time Director, who is presently a Non-Executive Non Independent Director of the company. Details as required under Regulation 30 read with SEBI Circular SEBI/ HOj49j14j14(7)2025-CFD-POD2jI/3762j2026, dated January 30, 2026 are enclosed herewith as Annexure-II 3. Notice, including explanatory statement therein, for convening 33rd Annual General Meeting of the Company scheduled to be held on September 29, 2026. 4. The cut-off date for determining the shareholders eligible of receiving the notice of ensuing Annual General Meeting scheduled to be held on September 29, 2026, shall be Friday, September 04, 2026 and for e-voting i.e. shareholders eligible to vote on the resolutions in notice of Annual General Meeting, shall be Tuesday, September 22, 2026. The Remote e voting period will commence on September 26, 2026 (9:00 A.M. 1ST) and ends on September 28, 2026 (5:00 P.M. 1ST). 5. Appointment of e-voting agency for facilitating e-voting including remote e-voting and the appointment of scrutinizer for providing scrutinizer's report thereon. You are requested to take the above intimations on record. Thanking You, For Orchid Pharma Limited KapilOayya Company Secretary & Compliance Officer Mem. No.- Fl0698 Encl. as above +91-44-27444471/72/73 corporate@orchidpharma.com orchidpharma.com CIN: L24222TN1992PLC022994 Registered Office: Corporate Office: Orchid Pharma Limited 15th Floor, Tower 1, DLF Corporate Greens, Sector 74A, Plot Nos. 121-128, 128A-133, 138-151, 159-164, SIDCO Industrial Estate, Gurugram - 122004, Haryana, India Alathur, Chengalpattu Dist - 603110, Tamil Nadu, India. OrchidPharm~W Annexure- I Information as required under Regulation 30 - Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 read with SEBI Circular SEBI/ HO/49/14/14(7)2025-CFD-POD2/I/3762/2026, dated January 30, 2026 (Appointment of Auditor) Particulars Appointment of Cost Auditor for FY 2026-2027 Name of the Audit Firm/Auditor M/s. J Karthik~an & Associates Reason for change viz. a ppoi ntment, Appointment resignation, removal, death or other'wise. Date of appointment & Term of The Board at their meeting held today i.e. appointment September 03, 2026, 2025, approved the appointment of Cost auditor for the F.Y.2026-27, subject to the ratification of remuneration of the cost auditor by the Members of the Company at the ensuing AGM. Brief Profile M/s. J Karthikeyan & Associates, Cost Accountant, Chennai, holding Certificate of Practice issued by the Institute of Cost Accountants of India (Membership No.29934, Firm Registration No.l02695) . Disclosure of relationships between Nil Directors +91-44-27444471/72/73 corporate@orchidpharma.com orchidpharma.com CIN: L24222TN1992PLC022994 Registered Office: Corporate Office: Orchid Pharma Limited 15th Floor, Tower 1, DLF Corporate Greens, Sector 74A, Plot Nos. 121-128, 128A-133, 138-151, 159-164, SIDCO Industrial Estate, Gurugram - 122004, Haryana, India Alathur, Chengalpattu Dist - 603110, Tamil Nadu, India. OrchidPharm~W Annexure- II Information as required under Regulation 30 - Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 read with SEBI Circular SEBI/ HO/49/14/14(7)2025-CFD-POD2/1/3762/2026, dated January 30, 2026 Sr. Particulars Information w.r.t Mr. Arjun No. Dhanuka 1 Reason for change viz. appointment, Change in designation resignation, removal, death or otherwise 2 Date of appointment/cessation (as September 03, 2026 applicable) & term of appointment Tenure- September 03, 2026 to September 02, 2031 3 Brief profile (in case of appointment) Mr. Arjun Dhanuka started his career with Dhanuka Laboratories Limited in September 2010. From 2010-13 his role comprised of managing all the purchase decisions of the Company. He graduated from Delhi University and has served as Whole Time Director of Dhanuka Laboratories Limited. In 2013, he started working with operations team of Synmedic Laboratories. After gaining relevant experience, he supervised majority of operations at Synmedic Laboratories since 2020. He strives in Business Development and strategy building. Mr. Dhanuka is young and dynamic person with an experience of more than a decade in the Pharmaceuticals Sector. 4 Disclosure of relationships between As per sec 2 (76) of Companies Act directors (in case of appointment of a 2013, Mr. Arjun Dhanuka is no director) related to other Directors and Key Managerial Personnel of the Company +91-44-27444471/72/73 corporate@orchidpharma.com orchidpharma.com CIN: L24222TN1992PLC022994 Registered Office: Corporate Office: Orchid Pharma Limited 15th Floor, Tower 1. DLF Corporate Greens, Sector 74A, Plot Nos. 121-128, 128A-133, 138-151,159-164, SIDCO Industrial Estate, Gurugram - 122004, Haryana, India Alathur, Chengalpattu Dist - 603110, Tamil Nadu, India.